151 related articles for article (PubMed ID: 9272236)
1. Cardiovascular and antiarrhythmic effects of the azulene-1-carboxamidine derivative N1,N1-dimethyl-N2-(2-pyridylmethyl)-5-isopropyl-3, 8-dimethylazulene-1-carboxamidine.
Saitoh M; Sugiyama A; Hagihara A; Nakazawa T; Hashimoto K
Arzneimittelforschung; 1997 Jul; 47(7):810-5. PubMed ID: 9272236
[TBL] [Abstract][Full Text] [Related]
2. A review of HNS-32: a novel azulene-1-carboxamidine derivative with multiple cardiovascular protective actions.
Tanaka Y; Shigenobu K
Cardiovasc Drug Rev; 2001; 19(4):297-312. PubMed ID: 11830749
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
Satoh K; Wada Y; Taira N
Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
[TBL] [Abstract][Full Text] [Related]
6. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
Kawada M; Satoh K; Taira N
J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
[TBL] [Abstract][Full Text] [Related]
7. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
[TBL] [Abstract][Full Text] [Related]
8. Effects of HNS-32, a novel antiarrhythmic drug, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats.
Saitoh M; Aye NN; Komori S; Nakazawa T; Hashimoto K
Mol Cell Biochem; 2000 Feb; 205(1-2):133-40. PubMed ID: 10821431
[TBL] [Abstract][Full Text] [Related]
9. HNS-32, a novel azulene-1-carboxamidine derivative, inhibits nifedipine-sensitive and -insensitive contraction of the isolated rabbit aorta.
Tanaka Y; Mitani A; Igarashi T; Someya S; Otsuka K; Imai T; Yamaki F; Tanaka H; Saitoh M; Nakazawa T; Noguchi K; Hashimoto K; Shigenobu K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):344-52. PubMed ID: 11284450
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological effects of penticainide in the anaesthetized dog.
Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
[TBL] [Abstract][Full Text] [Related]
11. Cerebral artery selective inhibition of protein kinase c-mediated contraction by hns-32, a novel azulene-1-carboxamidine derivative.
Noguchi K; Saitoh M; Nakazawa T; Tanaka H; Tanaka Y; Shigenobu K
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):45-54. PubMed ID: 11334370
[TBL] [Abstract][Full Text] [Related]
12. [Effects of a new antiarrhythmic drug, KW-3407, on canine ventricular arrhythmia models].
Wu Z; Awaji T; Motomura S; Hashimoto K
Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):117-26. PubMed ID: 1427497
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular actions of niludipine (BAY a 7168), a new dihydropyridine vasodilator, in the dog.
Taira N; Narimatsu A; Satoh K; Himori N; Imai Y; Hiwatari M
Arzneimittelforschung; 1979; 29(2):246-55. PubMed ID: 582137
[No Abstract] [Full Text] [Related]
14. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
Takahashi K; Taira N
Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
[TBL] [Abstract][Full Text] [Related]
16. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
[TBL] [Abstract][Full Text] [Related]
17. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
Satoh K; Yanagisawa T; Taira N
Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cardiovascular actions of CS-611, a new coronary dilator, in the dog.
Motomura S; Satoh K; Yamashita S; Taira N
Arzneimittelforschung; 1981; 31(8):1238-44. PubMed ID: 7197528
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog.
Sugiyama A; Motomura S; Tamura K; Hashimoto K
Jpn J Pharmacol; 1990 May; 53(1):97-110. PubMed ID: 2352380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
